Table 2.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95 % CI | P | HR | 95 % CI | P | |
Age (years) | 0.60 | 0.211–1.728 | 0.25 | |||
Gender | 1.02 | 0.297–3.559 | 0.60 | |||
Histological grade | 2.14 | 1.411–3.249 | 0.02* | 1.38 | 0.823–2.333 | 0.22 |
Metastasis | 2.61 | 0.710–9.655 | 0.12 | |||
Vein invasion | 1.19 | 0.404–3.527 | 0.48 | |||
Tumor size | 1.33 | 0.457–3.890 | 0.39 | |||
No. of tumor nodes | 2.61 | 0.890–7.685 | 0.06 | |||
Capsular formation | 0.86 | 0.298–2.502 | 0.50 | |||
HBsAg | 1.79 | 0.582–5.549 | 0.23 | |||
Cirrhosis | 1.52 | 0.466–4.980 | 0.34 | |||
Serum AFP level | 1.24 | 0.438–3.536 | 0.44 | |||
KIF3B | 4.26 | 2.14–10.84 | 0.006* | 6.736 | 2.249–19.315 | <0.01* |
Ki67 | 2.28 | 1.41–4.82 | 0.03* | 2.354 | 1.017–5.452 | 0.04* |
Statistical analyses were performed by the Cox test analysis
HCC human hepatocellular carcinoma, HR hazard ratio, CI confidence interval, HBsAg hepatitis B surface antigen, AFP alphafeto protein
* P < 0.05 was considered significant